NFE2L2 and non-small cell lung carcinoma: Therefore, we further implement survival analysis in NSCLC patients from MSK1661, OAK and POPLAR cohorts, and found that NFE2L2 MU did not have a significant association with OS (MSK1661, HR: 0.93, 95% CI 0.48 − 1.82; OAK, HR: 1.46, 95% CI 0.64–3.37; POPLAR, HR: 1.05, 95% CI 0.24 − 4.45; Additional file 1: Fig. S5B-D).